SEARCH

SEARCH BY CITATION

REFERENCES

  • Adam-Vizi V. (1992) External Ca2+-independent release of neurotransmitters. J. Neurochem. 58, 395405.
  • Andersen P. H. (1989) The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166, 493504.
  • Barasch J., Gershon M. D., Nunez E. A., Tamir H., and Al-Awqati Q. (1988) Thyrotropin induces the acidification of the secretory granules of parafollicular cells by increasing the chloride conductance of the granular membrane. J. Cell Biol. 107, 21372147.
  • Baughman R. W., Huettner J. E., Jones K. A., and Khan A. A. (1991) Cell culture of neocortex and basal forebrain from postnatal rats, in Culturing Nerve Cells (BankerG. and GoslinK., eds), pp. 227250. Bradford Press, Cambridge , Massachusetts .
  • Black I., Adler J. E., Dreyfus C. F., Friedman W. J., LaGamma E. F., and Roach A. H. (1987) Experience, neurotransmitter plasticity, and behavior, in Psychopharmacology: The Third Generation of Progress (MeltzerH., ed), pp. 463469. Raven Press, New York .
  • Bonnet J. J., Lemasson M. H., and Costentin J. (1984) Simultaneous evaluation by a double labeling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum. Biochem. Pharmacol. 33, 21292135.
  • Butcher S. P., Fairbrother I. S., Kelly J. S., and Arbuthnott G. W. (1988) Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study. J. Neurochem. 50, 346355.
  • Cho A. K. (1990) Ice: a new dosage form of an old drug. Science 249, 631634.
  • de Langen C. D. J. and Mulder A. H. (1980) Effects of psychotropic drugs on the distribution of 3H-dopamine into compartments of rat striatal synaptosomes and on subsequent depolarization-induced 3H-dopamine release. Naunyn Schmiedebergs Arch. Pharmacol. 311, 169177.
  • DiPorzio U., Dauget M. C., Glowinski J., and Prochiantz A. (1980) Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288, 370373.
  • Erecińska M., Pastuszko A., Wilson D. F., and Nelson D. (1987) Ammonia-induced release of neurotransmitters from rat brain synaptosomes: differences between the effects on amines and amino acids. J. Neurochem. 49, 12581265.
  • Fischer J. F. and Cho A. K. (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208, 203209.
  • Fuller R. W. and Snoddy H. D. (1979) Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine. J. Pharm. Pharmacol. 31, 183184.
  • Herdon H., Strupish J., and Nahorski S. R. (1985) Differences between the release of radiolabeled and endogenous dopamine from superfused rat brain slices: effects of depolarizing stimuli, amphetamine, and synthesis inhibition. Brain Res. 348, 309320.
  • Hurd Y. L. and Ungerstedt U. (1989) Ca2+ dependence of the amphetamine, nomifensine, and LY 19–005 effect on in vivo dopamine transmission. Eur. J. Pharmacol. 166, 261269.
  • Innis R. B., Malison R. T., Al-Tikriti M., Hoffer P. B., Sybirska E. H., Seibyl J. P., Zoghbi S. S., Baldwin R. M., Laruelle M., Smith E. O., Charney D. S., Heninger G., Elsworth J. D., and Roth R. H. (1992) Amphetamine-stimulated dopamine release competes in vivo for [123I]BZM binding to the D2 receptor in nonhuman primates. Synapse 10, 177184.
  • Johnson R. G. (1988) Accumulation of biological amines into chromaffin grarules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68, 232307.
  • Kamal L. A., Arbilla S., Galzin A. M., and Langer S. Z. (1983) Amphetamine inhibits the electrically evoked release of [3H]-dopamine from slices of the rabbit caudate. J. Pharmacol Exp. Ther. 227, 446458.
  • Kilty J. E., Lorang D., and Amara S. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578579.
  • Knepper S. M., Grunewald G. L., and Rutledge C. O. (1988) Inhibition of norepinephrine transport into synaptic vesicles by amphetamine analogs. J. Pharmacol. Exp. Ther. 247, 487494.
  • Krueger B. K. (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J. Neurochem. 55, 260267.
  • Kuhn L. J., Hadman M., and Sabban E. L. (1986) Effect of monensin on synthesis, posttranslational processing, and secretion of dopamine β-hydroxylase from PC12 pheochromocytoma cells. J. Biol. Chem. 261, 38163825.
  • Kuhr W. G., Ewing A. G., Near J. A., and Wightman R. M. (1985) Amphetamine attenuates the stimulated release of dopamine in vivo. J. Pharmacol. Exp. Ther. 232, 388394.
  • Kuijpers G. A. J., Rosario L. M., and Ornberg R. L. (1989) Role of intracellular pH in secretion from adrenal medulla chromaffin cells. J. Biol. Chem. 264, 698705.
  • Leitz F. H. and Stefano F. J. E. (1971) The effect of tyramine, amphetamine, and metaraminol on the metabolic disposition of 3H-norepinephrine released from the adrenergic neuron. J. Pharmacol. Exp. Ther. 178, 464473.
  • Liang N. Y. and Rutledge C. O. (1982) Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine, and unlabeled dopamine. Biochem. Pharmacol. 31, 983992.
  • Lonart G. and Zigmond M. J. (1991) High glutamate concentrations evoke Ca++-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256, 11321138.
  • Mack F. and Bonisch H. (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch. Pharmacol. 310, 19.
  • May L. J., Kuhr W. G., and Wightman R. M. (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J. Neurochem. 51, 10601069.
  • McMillen B. A. (1983) CNS stimulants: two distinct mechanisms of action for amphetamine-like drugs. Trends Pharmacol. Sci. 4, 429432.
  • Mefford I. N., Ota M., Stipetic M., and Singleton W. (1987) Application of a novel cation-exchange reagent, Igepon T-77 (N-methyl oleoyl taurate), to microbore separations of alumina extracts of catecholamines from cerebrospinal fluid, plasma, urine, and brain tissue with amperometric detection. J. Chromatogr. 420, 241251.
  • Okhuma S. and Poole B. (1981) Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J. Cell Biol. 90, 656664.
  • O'Malley D. M., Sandell J. H., and Masland R. H. (1992) Co-release of acetylcholine and GABA by the starburst amacrine cells. J. Neurosci. 12, 13941408.
  • Parker E. M. and Cubeddu L. X. (1986) Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. II. Release in the absence of vesicular transmitter stores. J. Pharmacol. Exp. Ther. 237, 179192.
  • Parsons L. H. and Justice J. B. (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J. Neurochem. 58, 212218.
  • Pasinetti G. M., Morgan D. G., Johnson S. A., Millar S. L., and Finch C. E. (1990) Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine. J. Neurochem. 55, 17931799.
  • Pin J. P. and Bockaert J. (1989) Two distinct mechanisms, differentially affected by excitatory amino acids, trigger GABA release from fetal mouse striatal neurons in primary culture. J. Neurosci. 9, 648656.
  • Raiteri M., Cerrito F., Cervoni A. M., and Levi G. (1979) Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther. 208, 195202.
  • Rayport S., Sulzer D., Shi W. X., Sawasdikosol S., Monaco J., Batson D., and Rajendran G. (1992) Identified postnatal mesolimbic dopamine neurons in culture: morphology and electrophysiology. J. Neurosci. 12, 42644280.
  • Reith M. A., Jacobson A. E., Rice K. C., Benuck M., and Zimanyi I. (1991) Effect of metaphit on dopaminergic neurotransmission in rat striatal slices: involvement of the dopamine transporter and voltage-dependent sodium channel. J. Pharmacol. Exp. Ther. 259, 11881196.
  • Ritz M. C., Lamb R. J., Goldberg S. R., and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 12191223.
  • Ritz M. C., Boja J. W., Grigoriadis D., Zaczek R., Carroll F. I., Lewis A. H., and Kuhar M. J. (1990) [3H]WIN 35,065–2: a ligand for cocaine receptors in striatum. J. Neurochem. 55, 15561562.
  • Rosenberg P. A. (1988) Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8, 28872894.
  • Rosenberg P. A. and Aizenman E. (1989) Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett. 103, 162168.
  • Rudnick G. and Wall S. C. (1992) The molecular mechanism of “ecstasy” [3,4-methylenedioxymethamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 89, 18171821.
  • Sabban E. L., Schwartz J., and McMahon A. (1990) Effects of compounds which disrupt proton gradients on secretion of neurosecretory proteins from PC12 pheochromocytoma cells. Neuroscience 38, 561570.
  • Schumann H. J. and Philippu A. (1962) Release of catecholamines from isolated medullary granules by sympathomimetic amines. Nature 193, 890891.
  • Shalaby I. A., Kotake C., Hoffmann P. C., and Heller A. (1983) Release of dopamine from coaggregate cultures of mesencephalic tegmentum and corpus striatum. J. Neurosci. 3, 15651571.
  • Shimada S., Kitayama S., Lin C. L., Patel A., Nanthakumar E., Gregor P. I., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576578.
  • Simon J. R., Yu H., Richter J. A., Vasko M. R., and Ghetti B. (1991) In vitro release of endogenous dopamine from the striatum of the weaver mutant mouse. J. Neurochem. 57, 14781482.
  • Stamford J. A., Kruk Z. L., and Millar J. (1989) Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data. Neuropharmacology 28, 13831388.
  • Sulzer D. and Holtzman E. (1988) Acidification and endosome-like compartments in the presynaptic terminals of frog retinal photoreceptors. J. Neurocytol. 18, 529540.
  • Sulzer D. and Rayport S. (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797808.
  • Sulzer, D. and Maidment, N. T. and Rayport, S. (1991) Reverse action of the plasma membrane transporter mediates weak base-induced dopamine release: implications for amphetamine action. Soc. Neurosci. Abstr. 17, 1552.
  • Sulzer D., Pothos E., Sung H. M., Maidment N. T., Hoebel B. G., and Rayport S. (1992a) Weak base model of amphetamine action. Ann. NY Acad. Sci. 654, 525528.
  • Sulzer D., Lau Y. Y., Ewing A. G., and Rayport S. (1992b) Amphetamine action examined in real-time in the giant dopamine neuron of Planorbis. Soc. Neurosci. Abstr. 18, 582.
  • Szatkowski M., Barbour B., and Attwell D. (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348, 443446.
  • Wise R. A. and Hoffman D. C. (1992) Localization of drug reward mechanisms by intracranial injections. Synapse 10, 247263.
  • Zaczek R., Hurt S., Culp S., and De Souza E. B. (1989) Characterization of brain interactions with methylenedioxyamphetamine and methylenedioxymethamphetamine. NIDA Res. Monogr. 94, 223239.
  • Zaczek R., Culp S., and De Souza E. B. (1991) Interactions of 3H-amphetamine with rat brain synaptosomes. II. Active transport. J. Pharmacol. Exp. Ther. 257, 830835.
  • ZetterstromT., SharpT., Collin, A. K., Ungerstedt, U., eds (1988) In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148, 327334.